Chandan Healthcare Q2 profit reaches Rs 18.20 crore on gain
Key highlights
- Chandan Healthcare reported Rs 18.20 crore of consolidated profit attributable to owners for the quarter ended 30 September 2026.
- A Rs 10.23 crore exceptional item lifted Q2 profit before tax to Rs 22.80 crore.
- Revenue from operations increased to Rs 58.00 crore from Rs 48.61 crore in the June 2026 quarter.
- The standalone cash-flow statement reported Rs 59.35 crore of capital-asset purchases in the first half.
powered by IRIS

Chandan Healthcare Limited reported consolidated profit attributable to owners of Rs 18.20 crore for the quarter ended 30 September 2026, supported by a Rs 10.23 crore exceptional item. Revenue from operations reached Rs 58.00 crore, while profit before exceptional items and tax was Rs 12.58 crore, compared with Rs 9.95 crore in the preceding quarter.
Know Chandan Healthcare inside out
Results, valuation, peers and who's buying, in one view.
What explains Chandan Healthcare’s Q2 profit increase?
Chandan Healthcare’s reported Q2 profit increase was principally supported by a Rs 10.23 crore exceptional item recorded in the quarter ended 30 September 2026. Profit before exceptional items and tax was Rs 12.58 crore, and the exceptional item lifted reported profit before tax to Rs 22.80 crore. The financial results do not state the nature of the exceptional item.
After tax expense of Rs 4.61 crore, Chandan Healthcare reported Rs 18.20 crore of profit from continuing operations and Rs 18.20 crore of profit attributable to owners. This compared with Rs 6.70 crore attributable to owners in the quarter ended 30 June 2026 and Rs 4.78 crore in the comparative column labelled quarter ended 30 June 2025. The September-quarter comparison includes the exceptional item, whereas the pre-exceptional profit measure does not.
Total comprehensive income was Rs 18.51 crore in the September 2026 quarter, comprising Rs 18.20 crore of profit attributable to owners and Rs 31.06 lakh of other comprehensive income. Basic earnings per share were Rs 7.44, up from Rs 2.74 in the June 2026 quarter, while diluted earnings per share were Rs 6.30, compared with Rs 2.32.
How did Chandan Healthcare’s revenue and expenses change?
Chandan Healthcare’s revenue from operations rose to Rs 58.00 crore in the quarter ended 30 September 2026 from Rs 48.61 crore in the preceding quarter. Including other income of Rs 1.80 crore, total revenue was Rs 59.80 crore, against Rs 49.34 crore in the June 2026 quarter. The comparative column labelled quarter ended 30 June 2025 reported operating revenue of Rs 39.16 crore.
Profit before exceptional items and tax increased to Rs 12.58 crore from Rs 9.95 crore as total revenue rose faster than total expenses. Total expenses were Rs 47.22 crore, compared with Rs 39.39 crore in the June quarter. The results therefore show a Rs 2.63 crore sequential increase in the pre-exceptional profit measure before the separate Rs 10.23 crore exceptional item was recognised.
Employee benefits expense increased to Rs 14.39 crore from Rs 12.67 crore quarter on quarter, while other expenses rose to Rs 14.19 crore from Rs 11.29 crore. Finance costs were Rs 4.84 crore, compared with Rs 4.06 crore, and depreciation and amortisation rose to Rs 4.63 crore from Rs 4.18 crore. Cost of material consumed was Rs 7.76 crore, while purchases of stock-in-trade declined to Rs 1.24 crore from Rs 1.49 crore.
Got a follow-up? Ask IRIS
What did Chandan Healthcare report for the first half?
Chandan Healthcare reported Rs 106.61 crore of revenue from operations for the half year ended 30 September 2026, compared with Rs 78.32 crore for the half year ended 30 September 2025. Total revenue was Rs 109.14 crore, including Rs 2.53 crore of other income, while total expenses were Rs 86.61 crore. Profit before exceptional items and tax reached Rs 22.53 crore, against Rs 14.19 crore in the corresponding half-year period.
The Rs 10.23 crore exceptional item, all recorded in the September quarter, raised first-half profit before tax to Rs 32.75 crore. Tax expense was Rs 7.86 crore, including a Rs 1.17 crore current-tax adjustment for earlier years. Profit attributable to owners was Rs 24.90 crore, compared with Rs 9.56 crore in the half year ended 30 September 2025.
Basic earnings per share for the first half were Rs 10.18, compared with Rs 3.91 in the corresponding period, and diluted earnings per share were Rs 8.61 against Rs 3.80. Total comprehensive income was Rs 25.44 crore, including Rs 54.50 lakh of other comprehensive income. The results report no profit or tax expense from discontinuing operations in either half-year period.
Chandan Healthcare adopted Indian Accounting Standards, or Ind AS, from 1 April 2026, using 1 April 2025 as the transition date. The company said the financial results for the quarter and half year ended 30 September 2026 were its first quarterly financial statements prepared under Ind AS. It restated or recast comparative information where applicable, with adjustments primarily relating to leases, financial instruments, employee benefits and deferred tax.
How did Chandan Healthcare’s balance sheet and cash flow move?
Chandan Healthcare’s consolidated total assets rose to Rs 382.16 crore at 30 September 2026 from Rs 267.38 crore at 31 March 2026. Property, plant and equipment increased to Rs 176.54 crore from Rs 132.34 crore, while capital work in progress grew to Rs 18.24 crore from Rs 11.90 crore. Trade receivables increased to Rs 69.01 crore from Rs 44.66 crore over the same period.
Cash and bank balances rose to Rs 31.86 crore at 30 September from Rs 3.15 crore at the March year-end. Other current assets increased to Rs 28.17 crore from Rs 10.17 crore, while inventories were broadly stable at Rs 15.99 crore compared with Rs 16.23 crore. Non-current investments declined to Rs 3.06 crore from Rs 12.52 crore.
The filing’s cash-flow statement is labelled standalone and reported Rs 29.54 crore of net cash flow from operating activities in the half year ended 30 September 2026. It recorded Rs 50.61 crore of net cash used in investing activities, including Rs 59.35 crore for the purchase of tangible and intangible assets. Net cash from financing activities was Rs 49.78 crore, producing a Rs 28.71 crore increase in cash and cash equivalents.
Long-term borrowings on the consolidated balance sheet increased to Rs 47.18 crore from Rs 28.58 crore, and short-term borrowings rose to Rs 28.56 crore from Rs 10.05 crore. The standalone cash-flow statement reported Rs 37.10 crore of net proceeds from long-term and short-term borrowings and Rs 21.52 crore of proceeds from share capital issuance, including share warrants. Money received against share warrants was Rs 14.02 crore at 30 September, down from Rs 26.03 crore at 31 March.
Conclusion
Chandan Healthcare’s September-quarter result combined a sequential rise in revenue from operations to Rs 58.00 crore and an increase in profit before exceptional items and tax to Rs 12.58 crore, with a Rs 10.23 crore exceptional item that lifted reported profit attributable to owners to Rs 18.20 crore. First-half operating revenue was Rs 106.61 crore and profit attributable to owners was Rs 24.90 crore.
The next disclosure will be relevant for the nature of the Rs 10.23 crore exceptional item, which is not explained in these results, and for the effect of Rs 59.35 crore of standalone capital-asset purchases. Readers can also track receivables of Rs 69.01 crore, borrowings of Rs 75.74 crore across long-term and short-term facilities, and comparability following Chandan Healthcare’s first-time Ind AS adoption.


